✦ LIBER ✦

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer

✍ Scribed by Nagio Takigawa; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Takuo Shibayama; Ichiro Takata; Hiroaki Miyamoto; Kenji Eguchi; Mine Harada

Publisher: Springer
Year: 2000
Tongue: English
Weight: 110 KB
Volume: 46
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000153

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, vindesine and bleomycin (CVB)

Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer

✍ Loretta M. Itri; Richard J. Gralla; David P. Kelsen; Robert A. Chapman; Ephraim 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Vindesine and high-dose cisplatin in the

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer

✍ Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Jo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Efficacy and tolerability of vindesine i

Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer

✍ D. A. L. Morgan 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 134 KB

Eighteen patients suffering from small-cell lung cancer, all with measurable lesions, were treated with vindesine (3 mg/m2 i.v. on days 1 and 8 of a 21-day cycle). Partial responses (PR) were seen in six patients (three of whom had been previously heavily treated). Most patients tolerated the drug e

Pilot phase II study of weekly chemother

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 192 KB

Cisplatin, ifosfamide and vindesine in t

Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study

✍ Ryoichi Honda; Akihisa Fujita; Yuhji Inoue; Mitsuo Asakawa; Akira Suzuki 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 315 KB

Phase I/II study of escalating doses of

Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer

✍ Fumihiro Oshita; Kouzo Yamada; Yuji Kato; Mizuki Ikehara; Kazumasa Noda; Gaku Ta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 154 KB